Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia.
Cancer Res. 2019 Sep 1;79(17):4309-4314. doi: 10.1158/0008-5472.CAN-19-0905. Epub 2019 Aug 6.
Whole-genome sequencing efforts of tumors and normal tissues have identified numerous genetic mutations, both somatic and germline, that do not overlap with coding genomic sequences. Attributing a functional role to these noncoding mutations and characterizing them using experimental methods has been more challenging compared with coding mutations. In this review, we provide a brief introduction to the world of noncoding mutations. We discuss recent progress in identifying noncoding mutations and the analytic and experimental approaches utilized to interpret their functional roles. We also highlight the potential mechanisms by which a noncoding mutation may exert its effect and discuss future challenges and opportunities.
全基因组测序技术已鉴定出许多非编码基因突变,包括体细胞和种系突变,这些突变与编码基因组序列不重叠。与编码突变相比,鉴定这些非编码突变的功能作用并通过实验方法对其进行特征描述更具挑战性。在这篇综述中,我们简要介绍了非编码突变的世界。我们讨论了最近在鉴定非编码突变方面的进展,以及用于解释其功能作用的分析和实验方法。我们还强调了非编码突变可能发挥作用的潜在机制,并讨论了未来的挑战和机遇。